Stachyose Improves the Effects of Berberine on Glucose Metabolism by Regulating Intestinal Microbiota and Short-Chain Fatty Acids in Spontaneous Type 2 Diabetic KKAy Mice
Berberine (BBR) has the beneficial effects of anti-inflammation, anti-bacteria, and anti-diabetes. The clinical application of BBR has been hindered by its poor gastrointestinal absorption. Stachyose (Sta), a prebiotic agent, improves the composition of gut microbiota and benefits for diabetes. We t...
Main Authors: | Hui Cao, Caina Li, Lei Lei, Xing Wang, Shuainan Liu, Quan Liu, Yi Huan, Sujuan Sun, Zhufang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.578943/full |
Similar Items
-
Effects of stachyose on intestinal microbiota and immunity in mice infected with enterotoxigenic Escherichia coli
by: Menglu Xi, et al.
Published: (2020-01-01) -
Berberine treatment-emergent mild diarrhea associated with gut microbiota dysbiosis
by: Shi-Jun Yue, et al.
Published: (2019-08-01) -
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study
by: Jie Ming, et al.
Published: (2021-08-01) -
Modulation of Microbiota-Gut-Brain Axis by Berberine Resulting in Improved Metabolic Status in High-Fat Diet-Fed Rats
by: Honglin Sun, et al.
Published: (2016-11-01) -
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
by: Min Wu, et al.
Published: (2020-03-01)